[1] |
Mcguire S. World cancer report 2014. Geneva, switzerland: world health organization, international agency for research on cancer, WHO press, 2015[J]. Adv Nutr, 2016,7(2): 418-419.
|
[2] |
Walter FM, Emery JD, Mendonca S, et al. Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study[J]. Br J Cancer, 2016,115(5): 533-541.
|
[3] |
Williams TG, Cubiella J, Griffin SJ, et al. Risk prediction models for colorectal cancer in people with symptoms: a systematic review[J]. BMC Gastroenterol, 2016,16(1): 63.
|
[4] |
Stearns MW Jr, Schottenfeld D. Techniques for the surgical manage ment of colon cancer[J]. Cancer, 1971, 28(1): 165-169.
|
[5] |
Li D, Hu J, Song H, et al. Mir-143-3p targeting lim domain kinase 1 suppresses the progression of triple-negative breast cancer cells[J]. Am J Transl Res, 2017, 9(5): 2276-2285.
|
[6] |
Shi H, Shen H, Xu J, et al. Mir-143-3p suppresses the progression of ovarian cancer[J]. Am J Transl Res, 2018, 10(3): 866-874.
|
[7] |
Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microrna function and dysfunction in cancer[J]. Nat Rev Genet, 2016, 17(12): 719-732.
|
[8] |
Moridikia A, Mirzaei H, Sahebkar A, et al. Micrornas: Potential candidates for diagnosis and treatment of colorectal cancer[J]. J Cell Physiol, 2018, 233(2): 901-913.
|
[9] |
Yang LH, Xie ZC, He RQ, et al. Identification of the potential targets of mir-143-3p in colorectal cancer through bioinformatics analysis[J]. Int J Clin Exp Med, 2017,10(2): 2188-2203.
|
[10] |
Yang F, Xie YQ, Tang SQ, et al. Mir-143 regulates proliferation and apoptosis of colorectal cancer cells and exhibits altered expression in colorectal cancer tissue[J]. Int J Clin Exp Med, 2015, 8(9): 15308-15312.
|
[11] |
Sun Y, Liu WZ, Liu T, et al. Signaling pathway of mapk/erk in cell proliferation, differentiation, migration, senescence and apoptosis[J]. J Recept Signal Transduct Res, 2015, 35(6): 600-604.
|
[12] |
Burotto M, Chiou VL, Lee JM, et al. The mapk pathway across different malignancies: a new perspective[J]. Cancer, 2014, 120(22): 3446-3456.
|
[13] |
Lei YY, Wang WJ, Mei JH, et al. Mitogen-activated protein kinase signal transduction in solid tumors[J]. Asian Pac J Cancer Pre, 2014, 15(20): 8539-8548.
|
[14] |
Wei WT, Nian XX, Wang SY, et al. Mir-422a inhibits cell proliferation in colorectal cancer by targeting akt1 and mapk1[J]. Cancer Cell Int, 2017, 17(1): 91-103.
|
[15] |
Upadhya D, Ogata M, Reneker LW. Mapk1 is required for establishing the pattern of cell proliferation and for cell survival during lens development[J]. Development, 2013, 140(7): 1573-1582.
|
[16] |
Yiwei T, Hua H, Hui G, et al. Hotair interacting with mapk1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion[J]. Med Sci Monit, 2015, 21(6): 1856-1863.
|
[17] |
Ouyang L, Shi Z, Zhao S, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis[J]. Cell Prolif, 2012, 45(6): 487-498..
|
[18] |
Shalini S, Dorstyn L, Dawar S, et al. Old, new and emerging functions of caspases[J]. Cell Death Differ, 2015, 22(4): 526-539.
|
[19] |
He Z, Yi J, Liu X, et al. Mir-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial–mesenchymal transition by targeting qki-5 in esophageal squamous cell carcinoma[J]. Mol Cancer, 2016, 15(1): 51-68.
|
[20] |
Sun X, Dai G, Yu L, et al. Mir-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting fosl2[J]. Sci Rep, 2018, 8(1): 606-616.
|